His primary areas of study are Osteoporosis, Bone density, Internal medicine, Bone mineral and Bone remodeling. His studies in Osteoporosis integrate themes in fields like Dentistry and Risk factor. The various areas that Ego Seeman examines in his Bone density study include Cortical bone, Lumbar vertebrae, Reduction and Bone resorption.
His Internal medicine study incorporates themes from Placebo and Endocrinology. Ego Seeman combines subjects such as Surgery, Vertebra, Urology, Physical exercise and Appendicular skeleton with his study of Bone mineral. His Bone remodeling research is multidisciplinary, relying on both Peak bone mass, Menopause, Anatomy and Resorption.
Ego Seeman mainly investigates Osteoporosis, Internal medicine, Endocrinology, Bone density and Bone mineral. His Osteoporosis research integrates issues from Physical therapy, Surgery and Bone remodeling. The Rheumatology, Vitamin D and neurology and Osteopenia research Ego Seeman does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as Osteocalcin, therefore creating a link between diverse domains of science.
His Endocrinology study combines topics in areas such as Parathyroid hormone and Calcium. His Bone density research incorporates themes from Cortical bone, Densitometry and Dentistry. His research links Urology with Bone mineral.
His primary scientific interests are in Internal medicine, Osteoporosis, Endocrinology, Bone remodeling and Bone density. His study in Osteoporosis is interdisciplinary in nature, drawing from both Cortical bone and Urology. His work in the fields of Menopause, vitamin D deficiency and Glucocorticoid overlaps with other areas such as Osteocalcin.
His research investigates the connection between Bone remodeling and topics such as Bone resorption that intersect with issues in Anabolism. His research integrates issues of Bone mineral, Vitamin D and neurology, Densitometry and Femoral neck in his study of Bone density. His work on Quantitative computed tomography as part of general Bone mineral study is frequently linked to N-terminal telopeptide, bridging the gap between disciplines.
His main research concerns Osteoporosis, Internal medicine, Bone remodeling, Bone density and Endocrinology. His work deals with themes such as Cortical bone and Menopause, which intersect with Osteoporosis. His Bone remodeling research is multidisciplinary, incorporating perspectives in Cortical porosity, Pharmacokinetics, Parathyroid hormone and Urology.
His Bone density research integrates issues from Bone mineral, Dentistry, Densitometry and FRAX. His work on Insulin resistance as part of his general Endocrinology study is frequently connected to Osteocalcin, thereby bridging the divide between different branches of science. His biological study spans a wide range of topics, including Placebo, Postmenopausal women and Surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
ASSESSMENT OF FRACTURE RISK AND ITS APPLICATION TO SCREENING FOR POSTMENOPAUSAL OSTEOPOROSIS
L Alexeeva;P Burkhardt;C Christiansen;C Cooper.
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis (1994)
Primer on the metabolic bone diseases and disorders of mineral metabolism
John P. Bilezikian;Roger Bouillon;Thomas Clemens;Juliet Compston.
Rhode Island dental journal (2013)
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
Uri A. Liberman;Stuart R. Weiss;Johann Broll;Helmut W. Minne.
The New England Journal of Medicine (1995)
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
Ego Seeman;Pierre D. Delmas.
The New England Journal of Medicine (2006)
The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis
Pierre J. Meunier;Christian Roux;Ego Seeman;Sergio Ortolani.
The New England Journal of Medicine (2004)
Risk of New Vertebral Fracture in the Year Following a Fracture
Robert Lindsay;Stuart L. Silverman;Cyrus Cooper;David A. Hanley.
JAMA (2001)
Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study
J Y. Reginster;E Seeman;M C. De Vernejoul;S Adami.
The Journal of Clinical Endocrinology and Metabolism (2005)
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study.
S.C.E Schuit;M van der Klift;A.E.A.M Weel;C.E.D.H de Laet.
Bone (2004)
Changes in Bone Mineral Density of the Proximal Femur and Spine with Aging: DIFFERENCES BETWEEN THE POSTMENOPAUSAL AND SENILE OSTEOPOROSIS SYNDROMES
B. L. Riggs;H. W. Wahner;E. Seeman;K. P. Offord.
Journal of Clinical Investigation (1982)
Pathogenesis of bone fragility in women and men.
Ego Seeman.
The Lancet (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Tokushima
University of Queensland
University of Melbourne
Deakin University
University of Lyon System
University of Melbourne
University of Melbourne
Bar-Ilan University
Monash University
University of Liège
Goethe University Frankfurt
Kennesaw State University
University of Malaya
University of Bristol
Griffith University
McGill University
University of Münster
Harvard University
Inserm : Institut national de la santé et de la recherche médicale
Vanderbilt University Medical Center
University of Alabama
University of Mississippi
University of Kentucky
University of Hong Kong
University of Salford
Columbia University